Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo
1998
TC21 Mutations in Breast Cancer
Sample size: 24
publication
Evidence: moderate
Author Information
Author(s): KT Barker, MR Crompton
Primary Institution: Institute of Cancer Research
Hypothesis
Are TC21 mutations present in breast carcinomas?
Conclusion
Mutations in TC21 are uncommon in breast carcinomas.
Supporting Evidence
- Only one breast cancer cell line, CAL51, showed a mutation in TC21.
- None of the nine primary breast cancer samples analyzed had TC21 mutations.
- The study confirmed that TC21 mutations are infrequent in breast carcinomas.
Takeaway
The study looked for mutations in a gene called TC21 in breast cancer but found that these mutations are very rare.
Methodology
The study used a single-strand conformational polymorphism (SSCP)-based assay to analyze cDNAs from breast, ovarian, and cervical cancer cell lines and tumors.
Limitations
The study only examined a limited number of breast cancer samples and may not represent all cases.
Want to read the original?
Access the complete publication on the publisher's website